Ezt az oldalt automatikusan lefordították, és a fordítás pontossága nem garantált. Kérjük, olvassa el a angol verzió forrásszöveghez.

Az alváshiány viszketésre és fájdalomérzékenységre gyakorolt ​​hatásának vizsgálata

2026. november 5. frissítette: Silvia Lo Vecchio, Aalborg University

Az alvási provokációk viszketésre és fájdalomérzékenységre gyakorolt ​​hatásának vizsgálata

In This experiment, the investigators would like to test following hypotheses regarding the influence of sleep deprivation on itch:

  • To investigate similarity and differences between itch and pain by comparing the effect of sleep deprivation in them.
  • To evaluate the inflammatory state induced by sleep fragmentation via the analysis of C-reactive protein (CRP) levels from blood samples.
  • To correlate the anxiety and depression scores (evaluated through questionnaires) with itch and pain sensitivity and evaluate how they are affected by sleep. In This experiment, the investigators would like to test following hypotheses regarding the influence of sleep fragmentation on itch:
  • To investigate similarity and differences between itch and pain by comparing the effect of sleep deprivation in them.
  • To evaluate the inflammatory state induced by sleep fragmentation via the analysis of C-reactive protein (CRP) levels from blood samples.
  • To correlate the anxiety and depression scores (evaluated through questionnaires) with itch and pain sensitivity and evaluate how they are affected by sleep deprivation.

A tanulmány áttekintése

Állapot

Toborzás

Részletes leírás

Chronic itch affects approximately a fifth of the global population and is associated with substantial negative consequences for the affected individuals. Furthermore, there is a lack of efficient treatment options for chronic itch. Poor sleep is a common companion of itch and is often reported by patients with chronic itch. Poor sleep is often characterized by nightly awakenings and troubles falling asleep. This is a significant problem as poor sleep in general is associated with lowered quality of life. While previous research has already established the negative impact of itch on sleep, it is yet to be studied whether the opposite tendency might be true as well. Knowledge about patients with chronic pain has shown that poor sleep can increase the sensitivity to pain and inflammation, and this tendency can also be observed in healthy participants after experimental sleep provocations. Therefore, the investigators wish to investigate how sleep provocations affect markers of itch in healthy participants.

Tanulmány típusa

Beavatkozó

Beiratkozás (Becsült)

30

Fázis

  • Nem alkalmazható

Kapcsolatok és helyek

Ez a rész a vizsgálatot végzők elérhetőségeit, valamint a vizsgálat lefolytatásának helyére vonatkozó információkat tartalmazza.

Tanulmányi kapcsolat

  • Név: Silvia Lo Vecchio
  • Telefonszám: +4521397785
  • E-mail: slv@hst.aau.dk

Tanulmányozza a kapcsolattartók biztonsági mentését

  • Név: kristian KS Petersen
  • Telefonszám: 31697510
  • E-mail: KKP@hst.aau.dk

Tanulmányi helyek

      • Aalborg, Dánia, 9620
        • Toborzás
        • Aalborg University
        • Kapcsolatba lépni:

Részvételi kritériumok

A kutatók olyan embereket keresnek, akik megfelelnek egy bizonyos leírásnak, az úgynevezett jogosultsági kritériumoknak. Néhány példa ezekre a kritériumokra a személy általános egészségi állapota vagy a korábbi kezelések.

Jogosultsági kritériumok

Tanulmányozható életkorok

18 év (Felnőtt)

Egészséges önkénteseket fogad

Igen

Tanulmányozható nemek

Összes

Leírás

Inclusion Criteria:

  • Healthy men and women
  • 18-60 years
  • Speak and understand English
  • Access to a smartphone during the experimental nights

Exclusion Criteria:

  • Pregnancy or lactation
  • Drug addiction defined as any use of cannabis, opioids, or other drugs
  • Previous or current history of neurological, dermatological, immunological musculoskeletal, cardiac disorder or mental illnesses (psychiatric diagnosis) that may affect the results (e.g., neuropathy, muscular pain in the upper extremities, anxiety, depression, schizophrenia etc.)
  • Moles, wounds, scars, or tattoos in the area to be treated or tested
  • Current use of medications that may affect the trial such as antihistamines and pain killers.
  • Skin diseases
  • Consumption of alcohol or painkillers 24 hours before the study days and between these
  • Acute or chronic pain and itch
  • Participation in other trials within 1 week of study entry (4 weeks in the case of pharmaceutical studies)
  • Lack of ability to cooperate

Tanulási terv

Ez a rész a vizsgálati terv részleteit tartalmazza, beleértve a vizsgálat megtervezését és a vizsgálat mérését.

Hogyan készül a tanulmány?

Tervezési részletek

  • Elsődleges cél: Alapvető tudomány
  • Kiosztás: N/A
  • Beavatkozó modell: Egyetlen csoportos hozzárendelés
  • Maszkolás: Nincs (Open Label)

Fegyverek és beavatkozások

Résztvevő csoport / kar
Beavatkozás / kezelés
Kísérleti: Sleep deprivation

This subproject will be conducted in two sessions separated by three nights of sleep deprivation. Each session will last approximately 2 hours. At the beginning of the first visit and after the last visit, 9 ml of blood will be drawn, and plasma will be isolated. After plasma isolation, the CRP concentration will be analyzed. In each forearm of the participant, a 4x4 cm area will be selected as Area of Interest (AOI). In these selected areas, itch will be induced in both sessions using histamine and cowhage and several tests will be conducted.

Histaminergic itch will be evoked by a 1% histamine solution. A droplet of histamine solution will be placed on the predetermined area on the forearm, and the SPT lancet will be pierced through the histamine with 120 g of pressure for 1-2 seconds

25 spicules will be inserted in the centre of the predefined skin area on the mandibular area. The spicules will be gently rubbed for 15-20 seconds in circular motion to facilitate epidermal penetration

Mit mér a tanulmány?

Elsődleges eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Assessment of itch
Időkeret: Day 1: 1 minute after every itch inductions

Immediately following the itch provocations, participants will be instructed to rate the itch intensity for 10 minutes using a digital visual analogue scale (VAS; eVAS Software: Aalborg, University, Denmark), on a tablet. The scale will be measured from 0 to 100, where 0 represents 'no itch' and 100 'worst itch imaginable'

Day 1: 1 minute after every itch inductions
Assessment of itch
Időkeret: Day 2: 1 minute after every itch inductions

Immediately following the itch provocations, participants will be instructed to rate the itch intensity for 10 minutes using a digital visual analogue scale (VAS; eVAS Software: Aalborg, University, Denmark), on a tablet. The scale will be measured from 0 to 100, where 0 represents 'no itch' and 100 'worst itch imaginable'

Day 2: 1 minute after every itch inductions
Assessment of pain
Időkeret: Day 1: 1 minute after every itch inductions

Immediately following the itch provocations, participants will be instructed to rate the pain intensity for 10 minutes using a digital visual analogue scale (VAS; eVAS Software: Aalborg, University, Denmark), on a tablet. The scale will be measured from 0 to 100, where 0 represents 'no pain' and 100 'worst pain imaginable'.

Day 1: 1 minute after every itch inductions
Assessment of pain
Időkeret: Day 2: 1 minute after every itch inductions

Immediately following the itch provocations, participants will be instructed to rate the pain intensity for 10 minutes using a digital visual analogue scale (VAS; eVAS Software: Aalborg, University, Denmark), on a tablet. The scale will be measured from 0 to 100, where 0 represents 'no pain' and 100 'worst pain imaginable'.

Day 2: 1 minute after every itch inductions

Másodlagos eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Microvascular reactivity
Időkeret: Day 1: 10 minutes after every itch inductions

Microvascular reactivity The evoked cutaneous inflammation (quantified by superficial blood perfusion) will be measured by full-field laser perfusion imaging

Day 1: 10 minutes after every itch inductions
Microvascular reactivity
Időkeret: Day 2: 10 minutes after every itch inductions

Microvascular reactivity The evoked cutaneous inflammation (quantified by superficial blood perfusion) will be measured by full-field laser perfusion imaging

Day 2: 10 minutes after every itch inductions
Touch Pleasantness (TP)
Időkeret: Day 1: 10 minutes after every itch inductions

Pleasant touch sensation measured using a standardized sensory brush (SENSELab Brush-05, Somedic AB, Hörby, Sweden) exerting a force of 200 to 400 mN.The stimulation consists of three strokes (2 cm in length) over the treated/control areas. The strokes will be applied perpendicularly to the skin and the subject will rate the sensation induced by the brush on a NRS scale labeled "very unpleasant" and "very pleasant" at the extremity and "neutral" at the center.

Day 1: 10 minutes after every itch inductions
Touch Pleasantness (TP)
Időkeret: Day 2: 10 minutes after every itch inductions

Pleasant touch sensation measured using a standardized sensory brush (SENSELab Brush-05, Somedic AB, Hörby, Sweden) exerting a force of 200 to 400 mN. The stimulation consists of three strokes (2 cm in length) over the treated/control areas. The strokes will be applied perpendicularly to the skin and the subject will rate the sensation induced by the brush on a NRS scale labeled "very unpleasant" and "very pleasant" at the extremity and "neutral" at the center.

Day 2: 10 minutes after every itch inductions
Mechanically evoked itch (MEI), intensity approach
Időkeret: Day 1: 10 minutes after every itch inductions

MEI is measured by using mildly pruritic, non-painful von Frey nylon filaments of a predetermined intensity (generally 5-30 miliNewton of force). This stimulator is moved in intervals of 0.5 cm outside the area of itch provocation. The subjects will report a score on a NRS scale ranging 0-10.

Day 1: 10 minutes after every itch inductions
Mechanically evoked itch (MEI), intensity approach
Időkeret: Day 2: 10 minutes after every itch inductions

MEI is measured by using mildly pruritic, non-painful von Frey nylon filaments of a predetermined intensity (generally 5-30 miliNewton of force). This stimulator is moved in intervals of 0.5 cm outside the area of itch provocation. The subjects will report a score on a NRS scale ranging 0-10.

Day 2: 10 minutes after every itch inductions
Mechanically evoked itch, spatial approach
Időkeret: Day 1: 10 minutes after every itch inductions

The von-Frey filament that better evokes the itch sensation during the assessment of mechanically evoked itch as well as a template of soft plastic are used to map the area of hyperkinesis in the test areas (forearms). The subjects will report a score on a NRS scale ranging 0-10.

Day 1: 10 minutes after every itch inductions
Mechanically evoked itch, spatial approach
Időkeret: Day 2: 10 minutes after every itch inductions

The von-Frey filament that better evokes the itch sensation during the assessment of mechanically evoked itch as well as a template of soft plastic are used to map the area of hyperkinesis in the test areas (forearms). The subjects will report a score on a NRS scale ranging 0-10.

Day 2: 10 minutes after every itch inductions
Mechanical Pain Thresholds (MPT)
Időkeret: Day 1: 10 minutes after every itch inductions

This test is conducted using a pinprick set (Aalborg University, Aalborg). The set consists of 7 needles each with a diameter of 0.6 mm and different force applications: 8, 16, 32, 64, 128, 256, and 512 mN. The subjects will report a score on a NRS scale ranging 0-10.

Day 1: 10 minutes after every itch inductions
Mechanical Pain Thresholds (MPT)
Időkeret: Day 2: 10 minutes after every itch inductions

This test is conducted using a pinprick set (Aalborg University, Aalborg). The set consists of 7 needles each with a diameter of 0.6 mm and different force applications: 8, 16, 32, 64, 128, 256, and 512 mN. The subjects will report a score on a NRS scale ranging 0-10.

Day 2: 10 minutes after every itch inductions
Mechanical Pain Sensitivity (MPS), intensity approach
Időkeret: Day 1: 10 minutes after every itch inductions

This test is conducted with the same pinprick set used to test the MPT. Starting with the lightest, each stimulator is applied at a rate of 2 s on, 2 s off in an ascending order, and the subject will be asked to give a pain rating for each stimulus on a scale from 0-10 (where 0 indicates ''no pain'', and 10 indicates the ''worst imaginable pain'') on a NRS.

Day 1: 10 minutes after every itch inductions
Mechanical Pain Sensitivity (MPS), intensity approach
Időkeret: Day 2: 10 minutes after every itch inductions

This test is conducted with the same pinprick set used to test the MPT. Starting with the lightest, each stimulator is applied at a rate of 2 s on, 2 s off in an ascending order, and the subject will be asked to give a pain rating for each stimulus on a scale from 0-10 (where 0 indicates ''no pain'', and 10 indicates the ''worst imaginable pain'') on a NRS.

Day 2: 10 minutes after every itch inductions
Cold Detection Thresholds (CDT) and heat (HPT) detection
Időkeret: Day 1: 10 minutes after every itch inductions

Thermal cold and heat stimuli will be applied by a contact heat-evoked potential stimulator (PATHWAYS; Medoc Ltd, Ramat Yishai, Israel), placed 5 cm distal to the elbow on the right dorsal forearm

Day 1: 10 minutes after every itch inductions
Cold Detection Thresholds (CDT) and heat (HPT) detection
Időkeret: Day 2: 10 minutes after every itch inductions

Thermal cold and heat stimuli will be applied by a contact heat-evoked potential stimulator (PATHWAYS; Medoc Ltd, Ramat Yishai, Israel), placed 5 cm distal to the elbow on the right dorsal forearm

Day 2: 10 minutes after every itch inductions
Cold Detection Thresholds (CDT) and heat (HPT) pain thresholds
Időkeret: Day 1: 10 minutes after every itch inductions

Thermal cold and heat stimuli will be applied by a contact heat-evoked potential stimulator (PATHWAYS; Medoc Ltd, Ramat Yishai, Israel), placed 5 cm distal to the elbow on the right dorsal forearm

Day 1: 10 minutes after every itch inductions
Cold Detection Thresholds (CDT) and heat (HPT) pain thresholds
Időkeret: Day 2: 10 minutes after every itch inductions

Thermal cold and heat stimuli will be applied by a contact heat-evoked potential stimulator (PATHWAYS; Medoc Ltd, Ramat Yishai, Israel), placed 5 cm distal to the elbow on the right dorsal forearm

Day 2: 10 minutes after every itch inductions
Pain to Supra-threshold Heat Stimuli (STHS)
Időkeret: Day 1: 10 minutes after every itch inductions

The tests will be conducted by using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device. A thermode stimulator of 3x3 cm will be placed on the treated/placebo areas and kept in place by means of Velcro tape. The subjects will rate the pain to three suprathreshold heat pain stimuli (starting and ending at 32°C with an increase and decrease of 5°C and 3 s plateau at 50°C).

Day 1: 10 minutes after every itch inductions
Pain to Supra-threshold Heat Stimuli (STHS)
Időkeret: Day 2: 10 minutes after every itch inductions

The tests will be conducted by using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device. A thermode stimulator of 3x3 cm will be placed on the treated/placebo areas and kept in place by means of Velcro tape. The subjects will rate the pain to three suprathreshold heat pain stimuli (starting and ending at 32°C with an increase and decrease of 5°C and 3 s plateau at 50°C).

Day 2: 10 minutes after every itch inductions
Deep-tissue Pain Sensitivity Measurements
Időkeret: Day 1: 10 minutes after every itch inductions

Deep-tissue pain sensitivity will be evaluated by cuff pressure stimuli using a computer-controlled cuff algometer (Cortex Technology and Aalborg University, Denmark) including a 13-cm wide tourniquet cuff (VBM, Sulz, Germany) and an electronic visual analog scale (VAS) (Aalborg University, Denmark) for recording of the pain intensity.

Day 1: 10 minutes after every itch inductions
Deep-tissue Pain Sensitivity Measurements
Időkeret: Day 2: 10 minutes after every itch inductions

Deep-tissue pain sensitivity will be evaluated by cuff pressure stimuli using a computer-controlled cuff algometer (Cortex Technology and Aalborg University, Denmark) including a 13-cm wide tourniquet cuff (VBM, Sulz, Germany) and an electronic visual analog scale (VAS) (Aalborg University, Denmark) for recording of the pain intensity.

Day 2: 10 minutes after every itch inductions
Pressure Detection and Tolerance Threshold
Időkeret: Day 1: 10 minutes after every itch inductions

The pressure will be increased by 1 kPa/s and the subject will be instructed to rate the pain intensity continuously on the electronic VAS until the tolerance level is reached.

Day 1: 10 minutes after every itch inductions
Pressure Detection and Tolerance Threshold
Időkeret: Day 2: 10 minutes after every itch inductions

The pressure will be increased by 1 kPa/s and the subject will be instructed to rate the pain intensity continuously on the electronic VAS until the tolerance level is reached.

Day 2: 10 minutes after every itch inductions
Temporal Summation of Pain - TSP
Időkeret: Day 1: 10 minutes after every itch inductions

A total of 10 repeated mechanical pressure stimuli at the PTT level will be delivered at 0.5 Hz (1 s stimulus duration and 1 s interval between stimuli) to the lower leg. A constant pressure of 5 kPa will be applied between the individual pressure stimuli to avoid movement of the cuff. During the 10 repeated stimuli, the subject will continuously rate the pain intensity on a 10 cm continuous VAS.

Day 1: 10 minutes after every itch inductions
Temporal Summation of Pain - TSP
Időkeret: Day 2: 10 minutes after every itch inductions

A total of 10 repeated mechanical pressure stimuli at the PTT level will be delivered at 0.5 Hz (1 s stimulus duration and 1 s interval between stimuli) to the lower leg. A constant pressure of 5 kPa will be applied between the individual pressure stimuli to avoid movement of the cuff. During the 10 repeated stimuli, the subject will continuously rate the pain intensity on a 10 cm continuous VAS.

Day 2: 10 minutes after every itch inductions
Conditioned Pain Modulation - CPM
Időkeret: Day 1: 10 minutes after every itch inductions

The concept of CPM is that a tonic painful stimulus (conditioning stimulus) will inhibit pain evoked simultaneously from another site (test stimulus). The painful conditioned stimulus will be applied simultaneously with the assessment

- Page 4 of 6 [DRAFT] - stimulus. The conditioned stimulus will be terminated right after the subject presses the stop button. CPM will be defined as the difference between stimulus during and before the conditioned pain (i.e., "during" minus "before").

Day 1: 10 minutes after every itch inductions
Conditioned Pain Modulation - CPM
Időkeret: Day 2: 10 minutes after every itch inductions

The concept of CPM is that a tonic painful stimulus (conditioning stimulus) will inhibit pain evoked simultaneously from another site (test stimulus). The painful conditioned stimulus will be applied simultaneously with the assessment

- Page 4 of 6 [DRAFT] - stimulus. The conditioned stimulus will be terminated right after the subject presses the stop button. CPM will be defined as the difference between stimulus during and before the conditioned pain (i.e., "during" minus "before").

Day 2: 10 minutes after every itch inductions
The Itch Catastrophizing Scale
Időkeret: Day 1

The itch catastrophizing scale is a modified version of the pain catastrophizing scale (PCS), which is a validated questionnaire measuring pain-related thoughts and feelings

Day 1
The Itch Catastrophizing Scale
Időkeret: Day 2

The itch catastrophizing scale is a modified version of the pain catastrophizing scale (PCS), which is a validated questionnaire measuring pain-related thoughts and feelings

Day 2
The Pittsburg Sleep Quality Index (PSQI)
Időkeret: Day 1

The PSQI consists of 19 items generating seven component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction.

Day 1
The Pittsburg Sleep Quality Index (PSQI)
Időkeret: Day 2

The PSQI consists of 19 items generating seven component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction.

Day 2
The Hospital Anxiety and Depression Scale (HADS)
Időkeret: Day 1

The HADS consists of 14 items with two 7-item subscales measuring anxiety and depression symptoms, respectively

Day 1
The Hospital Anxiety and Depression Scale (HADS)
Időkeret: Day 2

The HADS consists of 14 items with two 7-item subscales measuring anxiety and depression symptoms, respectively

Day 2
Positive and Negative Affective Schedule
Időkeret: Day 1

This 20-item instrument is a psychometric self-report test to assess affect (10 items for positive affect and 10 items for negative affect) and validated for the use in adolescents and adults

Day 1
Positive and Negative Affective Schedule
Időkeret: Day 2

This 20-item instrument is a psychometric self-report test to assess affect (10 items for positive affect and 10 items for negative affect) and validated for the use in adolescents and adults

Day 2
Blood Sampling for C-Reactive Protein Analysis
Időkeret: Day 1

Whole blood samples will be collected from the antecubital vein using a vacutainer blood collection device (SMonovette, Sarstedt) with a 21-gauge needle.

Day 1
Blood Sampling for C-Reactive Protein Analysis
Időkeret: Day 2

Whole blood samples will be collected from the antecubital vein using a vacutainer blood collection device (SMonovette, Sarstedt) with a 21-gauge needle.

Day 2

Együttműködők és nyomozók

Itt találhatja meg a tanulmányban érintett személyeket és szervezeteket.

Tanulmányi rekorddátumok

Ezek a dátumok nyomon követik a ClinicalTrials.gov webhelyre benyújtott vizsgálati rekordok és összefoglaló eredmények benyújtásának folyamatát. A vizsgálati feljegyzéseket és a jelentett eredményeket a Nemzeti Orvostudományi Könyvtár (NLM) felülvizsgálja, hogy megbizonyosodjon arról, hogy megfelelnek-e az adott minőség-ellenőrzési szabványoknak, mielőtt közzéteszik őket a nyilvános weboldalon.

Tanulmány főbb dátumok

Tanulmány kezdete (Tényleges)

2023. november 1.

Elsődleges befejezés (Tényleges)

2024. december 30.

A tanulmány befejezése (Becsült)

2026. december 31.

Tanulmányi regisztráció dátumai

Először benyújtva

2023. október 2.

Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak

2023. október 8.

Első közzététel (Tényleges)

2023. október 13.

Tanulmányi rekordok frissítései

Utolsó frissítés közzétéve (Tényleges)

2026. november 6.

Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak

2026. november 5.

Utolsó ellenőrzés

2026. november 1.

Több információ

A tanulmányhoz kapcsolódó kifejezések

Gyógyszer- és eszközinformációk, tanulmányi dokumentumok

Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz

Nem

Egy amerikai FDA által szabályozott eszközterméket tanulmányoz

Nem

Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .

Iratkozz fel